

Is Carisoprodol in shortage in 2026? Get the latest update on availability, costs, and what you can do if you can't find it.
If you've been told by your pharmacy that Carisoprodol isn't available, you're probably wondering: is there a nationwide shortage? The answer is complicated.
As of early 2026, standalone Carisoprodol tablets (250 mg and 350 mg) are not listed on the FDA's active drug shortage database. However, the combination product Carisoprodol/Aspirin has experienced documented shortages through ASHP (American Society of Health-System Pharmacists). And at the pharmacy level, many patients report difficulty finding Carisoprodol — even when it's not in an "official" shortage.
So what's going on? Let's break it down.
There's a difference between a formal drug shortage and real-world availability problems. A medication can be technically "in supply" at the manufacturer level while still being nearly impossible to find at your local pharmacy. Here's why this happens with Carisoprodol:
Carisoprodol is a DEA Schedule IV controlled substance. This means pharmacies face strict regulations on ordering, storing, and dispensing it. Distributors may cap how much a pharmacy can order based on historical purchasing patterns. If a pharmacy hasn't been filling many Carisoprodol prescriptions, it may struggle to order enough when demand increases.
The number of companies making generic Carisoprodol has decreased over the years. Fewer manufacturers means the supply chain is more fragile — a production delay at even one facility can create widespread availability issues.
Some large chain pharmacies have reduced how much Carisoprodol they stock or have stopped carrying it altogether. This is often an internal corporate decision based on liability concerns around controlled substances with abuse potential. For a deeper explanation, see our article on why Carisoprodol is so hard to find.
Many insurance plans require prior authorization or step therapy before covering Carisoprodol. Step therapy means you need to try a non-controlled muscle relaxant — like Cyclobenzaprine or Methocarbamol — before your plan will pay for Carisoprodol. This reduces overall prescribing volume, which in turn gives pharmacies less reason to keep it in stock.
Cost depends on whether you have insurance and which pharmacy you use:
For a full breakdown of ways to save, check out our Carisoprodol savings guide.
While no new muscle relaxants have launched recently, there are new tools and resources that make it easier to find and afford Carisoprodol:
Here's a step-by-step approach:
For more detailed strategies, read our full guide on how to find Carisoprodol in stock near you.
Carisoprodol isn't in a formal nationwide shortage in 2026, but real-world availability remains a challenge for many patients. The combination of controlled substance restrictions, fewer manufacturers, pharmacy policies, and insurance hurdles creates a frustrating situation.
The best thing you can do is be proactive. Use Medfinder to locate stock, explore independent pharmacies, and have an open conversation with your doctor about your options. You deserve access to the medication that works for you — and there are more ways than ever to find it.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.